Cargando…
Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms
Background: Schizophrenia is a severe and enduring disease and is one of the leading causes of disability worldwide. Cognitive impairment is a core clinical symptom that plays a crucial role in functional outcomes and prognosis, thus making it a relevant treatment target. The aim of this study was t...
Autores principales: | Recio-Barbero, María, Segarra, Rafael, Zabala, Arantzazu, González-Fraile, Eduardo, González-Pinto, Ana, Ballesteros, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055861/ https://www.ncbi.nlm.nih.gov/pubmed/33889097 http://dx.doi.org/10.3389/fpsyt.2021.631589 |
Ejemplares similares
-
Impact of Nicotine on Cognition in Patients With Schizophrenia: A Narrative Review
por: Spasova, Violeta, et al.
Publicado: (2022) -
Self-Awareness Deficits of Cognitive Impairment in Individuals With Schizophrenia. Really?
por: Raffard, Stéphane, et al.
Publicado: (2020) -
Neuronal Nicotinic Acetylcholine Receptors: Common Molecular Substrates of Nicotine and Alcohol Dependence
por: Hendrickson, Linzy M., et al.
Publicado: (2013) -
Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
por: Takeda, Kazuyoshi, et al.
Publicado: (2018) -
Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
por: Bali, Zsolt Kristóf, et al.
Publicado: (2019)